SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-080254
Filing Date
2015-11-19
Accepted
2015-11-19 16:41:20
Documents
2
Period of Report
2015-11-19

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6073
2 EX-24 ex-24.htm EX-24 7483
  Complete submission text file 0001104659-15-080254.txt   14894
Mailing Address 11388 SORRENTO VALLEY ROAD STE. 200 SAN DIEGO CA 92121
Business Address
Kaye Randall (Reporting) CIK: 0001350416 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37635 | Film No.: 151244101

Mailing Address 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY 10111
Business Address 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY 10111 212-203-5072
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations